Evaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19
<br><strong>Background: </strong>At the start of the coronavirus disease 2019 (COVID-19) pandemic there was widespread concern about potentially overwhelming demand for intensive care and the need for intensive care unit (ICU) triage. In March 2020, a draft United Kingdom (UK) guid...
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
F1000Research
2021
|
_version_ | 1811139465090957312 |
---|---|
author | Simon Thomas, E Peiris, B Di Stefano, L Rowland, MJ Wilkinson, D |
author_facet | Simon Thomas, E Peiris, B Di Stefano, L Rowland, MJ Wilkinson, D |
author_sort | Simon Thomas, E |
collection | OXFORD |
description | <br><strong>Background: </strong>At the start of the coronavirus disease 2019 (COVID-19) pandemic there was widespread concern about potentially overwhelming demand for intensive care and the need for intensive care unit (ICU) triage. In March 2020, a draft United Kingdom (UK) guideline proposed a decision-support tool (DST). We sought to evaluate the accuracy of the tool in patients with COVID-19.
<br><strong>
Methods: </strong>We retrospectively identified patients in two groups: referred and not referred to intensive care in a single UK national health service (NHS) trust in April 2020. Age, Clinical Frailty Scale score (CFS), and co-morbidities were collected from patients’ records and recorded, along with ceilings of treatment and outcome. We compared the DST, CFS, and age alone as predictors of mortality, and treatment ceiling decisions.
<br><strong>
Results:</strong> In total, 151 patients were included in the analysis, with 75 in the ICU and 76 in the non-ICU-reviewed groups. Age, clinical frailty and DST score were each associated with increased mortality and higher likelihood of treatment limitation (p-values all <.001). A DST cut-off score of >8 had 65% (95% confidence interval (CI) 51%-79%) sensitivity and 63% (95% CI 54%-72%) specificity for predicting mortality. It had a sensitivity of 80% (70%-88%) and specificity of 96% (95% CI 90%-100%) for predicting treatment limitation. The DST was more discriminative than age alone (p<0.001), and potentially more discriminative than CFS (p=0.08) for predicting treatment ceiling decisions.
<br><strong>
Conclusions: </strong>During the first wave of the COVID-19 pandemic, in a hospital without severe resource limitations, a hypothetical decision support tool was limited in its predictive value for mortality, but appeared to be sensitive and specific for predicting treatment limitation. |
first_indexed | 2024-03-07T08:25:42Z |
format | Journal article |
id | oxford-uuid:1b07b4ba-891d-44ff-8608-48fc46b2434e |
institution | University of Oxford |
language | English |
last_indexed | 2024-09-25T04:06:31Z |
publishDate | 2021 |
publisher | F1000Research |
record_format | dspace |
spelling | oxford-uuid:1b07b4ba-891d-44ff-8608-48fc46b2434e2024-06-05T10:58:50ZEvaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1b07b4ba-891d-44ff-8608-48fc46b2434eEnglishSymplectic ElementsF1000Research2021Simon Thomas, EPeiris, BDi Stefano, LRowland, MJWilkinson, D<br><strong>Background: </strong>At the start of the coronavirus disease 2019 (COVID-19) pandemic there was widespread concern about potentially overwhelming demand for intensive care and the need for intensive care unit (ICU) triage. In March 2020, a draft United Kingdom (UK) guideline proposed a decision-support tool (DST). We sought to evaluate the accuracy of the tool in patients with COVID-19. <br><strong> Methods: </strong>We retrospectively identified patients in two groups: referred and not referred to intensive care in a single UK national health service (NHS) trust in April 2020. Age, Clinical Frailty Scale score (CFS), and co-morbidities were collected from patients’ records and recorded, along with ceilings of treatment and outcome. We compared the DST, CFS, and age alone as predictors of mortality, and treatment ceiling decisions. <br><strong> Results:</strong> In total, 151 patients were included in the analysis, with 75 in the ICU and 76 in the non-ICU-reviewed groups. Age, clinical frailty and DST score were each associated with increased mortality and higher likelihood of treatment limitation (p-values all <.001). A DST cut-off score of >8 had 65% (95% confidence interval (CI) 51%-79%) sensitivity and 63% (95% CI 54%-72%) specificity for predicting mortality. It had a sensitivity of 80% (70%-88%) and specificity of 96% (95% CI 90%-100%) for predicting treatment limitation. The DST was more discriminative than age alone (p<0.001), and potentially more discriminative than CFS (p=0.08) for predicting treatment ceiling decisions. <br><strong> Conclusions: </strong>During the first wave of the COVID-19 pandemic, in a hospital without severe resource limitations, a hypothetical decision support tool was limited in its predictive value for mortality, but appeared to be sensitive and specific for predicting treatment limitation. |
spellingShingle | Simon Thomas, E Peiris, B Di Stefano, L Rowland, MJ Wilkinson, D Evaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19 |
title | Evaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19 |
title_full | Evaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19 |
title_fullStr | Evaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19 |
title_full_unstemmed | Evaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19 |
title_short | Evaluation of a hypothetical decision-support tool for intensive care triage of patients with COVID-19 |
title_sort | evaluation of a hypothetical decision support tool for intensive care triage of patients with covid 19 |
work_keys_str_mv | AT simonthomase evaluationofahypotheticaldecisionsupporttoolforintensivecaretriageofpatientswithcovid19 AT peirisb evaluationofahypotheticaldecisionsupporttoolforintensivecaretriageofpatientswithcovid19 AT distefanol evaluationofahypotheticaldecisionsupporttoolforintensivecaretriageofpatientswithcovid19 AT rowlandmj evaluationofahypotheticaldecisionsupporttoolforintensivecaretriageofpatientswithcovid19 AT wilkinsond evaluationofahypotheticaldecisionsupporttoolforintensivecaretriageofpatientswithcovid19 |